Akiko Iwasaki - Nanotechnology

Author Information

Akiko Iwasaki is a prominent researcher affiliated with the Department of Immunobiology at Yale University School of Medicine, located in New Haven, CT 06520. Her extensive work in the field of immunology has made significant contributions to our understanding of immune responses, particularly in the context of viral infections such as SARS-CoV-2.

Research Contributions

Akiko Iwasaki has made substantial contributions to the field of immunobiology, with a particular focus on viral immunology and the immune system's response to infections. In 2022 alone, she published numerous influential papers on topics such as SARS-CoV-2 variants, immune dysregulation from mild respiratory infections, and the development of therapeutic antibodies. Her research has provided critical insights into the mechanisms of immune response and potential therapeutic interventions for COVID-19 and other viral infections.

Aliases

The author is also known by several aliases including A. Iwasaki and A Iwasaki. However, her full name, Akiko Iwasaki, is most commonly used in her publications and professional affiliations.

Publication and Citation Metrics

Metric	Value
Citation Count	54,015
H-index	103
Paper Count	406

Publications:

A synthetic bispecific antibody capable of neutralizing SARS-CoV-2 Delta and Omicron

DOI: 10.1101/2022.01.04.474803

Year: 2022

Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain

DOI: 10.1101/2022.01.07.475453

Year: 2022

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration

DOI: 10.1101/2022.02.03.478946

Year: 2022

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

DOI: 10.1038/s41467-021-27716-4

Year: 2022

Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion

DOI: 10.1073/pnas.2117198119

Year: 2022

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report

DOI: 10.1038/s41467-022-29104-y

Year: 2022

Lack of association between pandemic chilblains and SARS-CoV-2 infection

DOI: 10.1073/pnas.2122090119

Year: 2022

UVB-mediated DNA damage induces matrix metalloproteinases to promote photoaging in an AhR- and SP1-dependent manner.

DOI: 10.1172/jci.insight.156344

Year: 2022

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

DOI: 10.1038/s41591-022-01705-6

Year: 2022

Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses

DOI: 10.1101/2022.01.24.477597

Year: 2022

How to Overcome Challenges in Collaborative Learning?

Why Use Enzymes in Nanotechnology?

How Do Regulatory Specialists Stay Informed?

How Can Nanotechnology Help in Diagnosing Glaucoma?

What Role Does Software Play in Managing Computational Costs?

What are Some Applications of Nanotechnology at the Atomic and Molecular Scale?

What is Nanotechnology-Based Sensing?

What is Depth of Focus?

How Do Digital Control Systems Work in Nanotechnology?

What is the Importance of Chemical Composition?

Partnered Content Networks

Relevant Topics